News

Study compares tools for Cushing’s diagnosis, tumor localization

Magnetic resonance imaging (MRI) is a useful tool for pinpointing the location of a pituitary tumor that causes Cushing’s disease prior to surgery, a recent study reported. However, study findings indicate that bilateral inferior petrosal sinus sampling (BIPSS), an invasive diagnostic procedure, is more accurate for the initial…

Signifor Controls Ectopic Cushing’s Symptoms in Woman for 5 Years

Signifor (pasireotide) treatment was able to control symptoms of ectopic Cushing’s syndrome in a woman for years, according to a case report. The report, “Complete and sustained remission of hypercortisolism with pasireotide treatment of an adrenocorticotropic hormone (ACTH)-secreting thoracic neuroendocrine tumour: an n-of-1 trial,” was published in…

Approved Therapy Recorlev Now Wins FDA Orphan-drug Exclusivity

The U.S. Food and Drug Administration (FDA) has granted Xeris Pharmaceuticals orphan-drug exclusivity for Recorlev (levoketoconazole), its approved treatment for adults with endogenous Cushing’s syndrome. Orphan-drug exclusivity provides the company — which recently acquired the therapy’s developer, Strongbridge Biopharma — seven years of marketing exclusivity for Recorlev…

Case Report: Adrenal Gland Cancer Caused Cushing’s

The case of a woman with adrenal gland cancer that caused Cushing’s syndrome in its advanced stages was described in a recent report. Authors noted this study highlights the difficulties in care for people with aggressive adrenal tumors, which often don’t cause noticeable symptoms until the disease is at a…